Abstract
Respiratory tract infections (RTIs) are extremely common and can cause gastrointestinal tract symptoms and changes to the gut microbiota, yet these effects are poorly understood. We conducted a systematic review to evaluate the reported evidence of gut microbiome alterations in patients with a RTI compared to healthy controls (PROSPERO: CRD42019138853). We systematically searched Medline, Embase, Web of Science, Cochrane and the Clinical Trial Database for studies published between January 2015 and June 2021. Studies were eligible for inclusion if they were human cohorts describing the gut microbiome in patients with an RTI compared to healthy controls and the infection was caused by a viral or bacterial pathogen. Dual data screening and extraction with narrative synthesis was performed. We identified 1,593 articles and assessed 11 full texts for inclusion. Included studies (some nested) reported gut microbiome changes in the context of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (n = 5), influenza (H1N1 and H7N9) (n = 2), Tuberculosis (TB) (n = 4), Community-Acquired Pneumonia CAP (n = 2) and recurrent RTIs (rRTI) (n = 1) infections. We found studies of patients with an RTI compared to controls reported a decrease in gut microbiome diversity (Shannon) of 1.45 units (95% CI, 0.15–2.50 [p, <0.0001]) and a lower abundance of taxa (p, 0.0086). Meta-analysis of the Shannon value showed considerable heterogeneity between studies (I2, 94.42). Unbiased analysis displayed as a funnel plot revealed a depletion of Lachnospiraceae, Ruminococcaceae and Ruminococcus and enrichment of Enterococcus. There was an important absence in the lack of cohort studies reporting gut microbiome changes and high heterogeneity between studies may be explained by variations in microbiome methods and confounder effects. Further human cohort studies are needed to understand RTI-induced gut microbiome changes to better understand interplay between microbes and respiratory health.
Funder
Wellcome Trust Institutional Strategic Support Fund
Medical Research Council
Daphne Jackson Trust
Publisher
Public Library of Science (PLoS)
Reference74 articles.
1. Resource use and direct medical costs of acute respiratory illness in the UK based on linked primary and secondary care records from 2001 to 2009;G.C. Meier;PLoS One,2020
2. WHO covid-19 dashboard. 2020; https://covid19.who.int/?gclid=CjwKCAiA_eb-BRB2EiwAGBnXXiTJC9zp-D8v1G3Out2_Yz_jgFQN_N2SDEqV9fJxrNP_t-oDFhIrbBoC6ncQAvD_BwE.
3. Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management;F. D’Amico;Clin Gastroenterol Hepatol,2020
4. The role of mucosal barriers in human gut health;K. Seo;Arch Pharm Res,2021
5. Modulation of gut microbiota protects against viral respiratory tract infections: a systematic review of animal and clinical studies;H.Y. Shi;Eur J Nutr,2021
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献